NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Trevi Therapeutics Inc (NASDAQ: TRVI)
TRVI Technical Analysis
4
As on 9th Jun 2023 TRVI STOCK Price closed @ 2.57 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.15 & Strong Buy for SHORT-TERM with Stoploss of 0.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TRVISTOCK Price
Open | 2.50 | Change | Price | % |
High | 2.63 | 1 Day | 0.03 | 1.18 |
Low | 2.50 | 1 Week | 0.41 | 18.98 |
Close | 2.57 | 1 Month | -0.85 | -24.85 |
Volume | 197800 | 1 Year | 1.88 | 272.46 |
52 Week High 4.28 | 52 Week Low 0.46 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
TRVI Daily Charts |
TRVI Intraday Charts |
Whats New @ Bazaartrend |
TRVI Free Analysis |
|
TRVI Important Levels Intraday
RESISTANCE | 2.82 |
RESISTANCE | 2.74 |
RESISTANCE | 2.69 |
RESISTANCE | 2.64 |
SUPPORT | 2.50 |
SUPPORT | 2.45 |
SUPPORT | 2.40 |
SUPPORT | 2.32 |
TRVI Forecast May 2024
4th UP Forecast | 3.3 |
3rd UP Forecast | 3.07 |
2nd UP Forecast | 2.92 |
1st UP Forecast | 2.78 |
1st DOWN Forecast | 2.36 |
2nd DOWN Forecast | 2.22 |
3rd DOWN Forecast | 2.07 |
4th DOWN Forecast | 1.84 |
TRVI Weekly Forecast
4th UP Forecast | 2.84 |
3rd UP Forecast | 2.75 |
2nd UP Forecast | 2.70 |
1st UP Forecast | 2.65 |
1st DOWN Forecast | 2.49 |
2nd DOWN Forecast | 2.44 |
3rd DOWN Forecast | 2.39 |
4th DOWN Forecast | 2.30 |
TRVI Forecast2024
4th UP Forecast | 10.7 |
3rd UP Forecast | 8.09 |
2nd UP Forecast | 6.48 |
1st UP Forecast | 4.87 |
1st DOWN Forecast | 0.27 |
2nd DOWN Forecast | -1.34 |
3rd DOWN Forecast | -2.95 |
4th DOWN Forecast | -5.56 |
Trevi Therapeutics Inc ( NASDAQ USA Symbol : TRVI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TRVI Other Details
Segment | EQ | |
Market Capital | 28948192.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
TRVI Address
TRVI Latest News
TRVI Business Profile
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, which is in Phase IIb/III clinical trial is an oral extended release formulation of nalbuphine that is used for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease, as well as to treat chronic kidney disease-associated with pruritus. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation; and Rutgers to develop and commercialize products incorporating nalbuphine for any human or animal use. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut. Address: 195 Church Street, New Haven, CT, United States, 06510
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service